These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 19895984)
1. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. Haselkorn T; Zeiger RS; Chipps BE; Mink DR; Szefler SJ; Simons FE; Massanari M; Fish JE J Allergy Clin Immunol; 2009 Nov; 124(5):921-7. PubMed ID: 19895984 [TBL] [Abstract][Full Text] [Related]
2. Recent asthma exacerbations: a key predictor of future exacerbations. Miller MK; Lee JH; Miller DP; Wenzel SE; Respir Med; 2007 Mar; 101(3):481-9. PubMed ID: 16914299 [TBL] [Abstract][Full Text] [Related]
3. [Predictive factors associated with severity of asthma exacerbations]. Atiş S; Kaplan ES; Ozge C; Bayindir S Tuberk Toraks; 2008; 56(2):187-96. PubMed ID: 18701979 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations. Zeiger RS; Yegin A; Simons FE; Haselkorn T; Rasouliyan L; Szefler SJ; Chipps BE; Ann Allergy Asthma Immunol; 2012 Feb; 108(2):81-7. PubMed ID: 22289725 [TBL] [Abstract][Full Text] [Related]
5. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Dolan CM; Fraher KE; Bleecker ER; Borish L; Chipps B; Hayden ML; Weiss S; Zheng B; Johnson C; Wenzel S; Ann Allergy Asthma Immunol; 2004 Jan; 92(1):32-9. PubMed ID: 14756462 [TBL] [Abstract][Full Text] [Related]
6. Clinical and economic effects of suboptimally controlled asthma. Bootman JL; Crown WH; Luskin AT Manag Care Interface; 2004 Jan; 17(1):31-6. PubMed ID: 15035598 [TBL] [Abstract][Full Text] [Related]
7. Understanding mild persistent asthma in children: the next frontier. Bisgaard H; Szefler SJ J Allergy Clin Immunol; 2005 Apr; 115(4):708-13. PubMed ID: 15805988 [TBL] [Abstract][Full Text] [Related]
8. Ratio of controller to total asthma medications: determinants of the measure. Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912 [TBL] [Abstract][Full Text] [Related]
9. [Round Table: Severe asthma in pediatrics: diagnosis and prognosis]. Garde Garde JM; Medina Pomares J Allergol Immunopathol (Madr); 1999; 27(2):46-53. PubMed ID: 10354006 [TBL] [Abstract][Full Text] [Related]
10. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. Chipps BE; Szefler SJ; Simons FE; Haselkorn T; Mink DR; Deniz Y; Lee JH; J Allergy Clin Immunol; 2007 May; 119(5):1156-63. PubMed ID: 17397912 [TBL] [Abstract][Full Text] [Related]
11. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. Haselkorn T; Fish JE; Zeiger RS; Szefler SJ; Miller DP; Chipps BE; Simons FE; Weiss ST; Wenzel SE; Borish L; Bleecker ER; J Allergy Clin Immunol; 2009 Nov; 124(5):895-902.e1-4. PubMed ID: 19811812 [TBL] [Abstract][Full Text] [Related]
12. Fetal sex and maternal asthma control in pregnancy. Bakhireva LN; Schatz M; Jones KL; Tucker CM; Slymen DJ; Klonoff-Cohen HS; Gresham L; Johnson D; Chambers CD; J Asthma; 2008 Jun; 45(5):403-7. PubMed ID: 18569234 [TBL] [Abstract][Full Text] [Related]
13. [Induced sputum--means for detecting bronchial inflammation in children with atopic bronchial asthma and treatment monitoring]. Soşa IP; Nanulescu M Pneumologia; 2004; 53(3):79-84. PubMed ID: 16108154 [TBL] [Abstract][Full Text] [Related]
14. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Peters SP; Ferguson G; Deniz Y; Reisner C Respir Med; 2006 Jul; 100(7):1139-51. PubMed ID: 16713224 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk factors and health outcomes among persons with asthma. Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629 [TBL] [Abstract][Full Text] [Related]
16. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715 [TBL] [Abstract][Full Text] [Related]
17. Exhaled nitric oxide as a predictor of exacerbation in children with moderate-to-severe asthma: a prospective, 5-month study. Cabral AL; Vollmer WM; Barbirotto RM; Martins MA Ann Allergy Asthma Immunol; 2009 Sep; 103(3):206-11. PubMed ID: 19788017 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511 [TBL] [Abstract][Full Text] [Related]
19. Identifying an at-risk population of children with recurrent near-fatal asthma exacerbations. Carroll CL; Uygungil B; Zucker AR; Schramm CM J Asthma; 2010 May; 47(4):460-4. PubMed ID: 20528602 [TBL] [Abstract][Full Text] [Related]
20. The challenge of mild persistent asthma. Irani AM Ann Allergy Asthma Immunol; 2005 May; 94(5):517-27; quiz 527-9, 574. PubMed ID: 15945553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]